vs
弗雷斯特研究公司（FORR）与Oncology Institute, Inc.（TOI）财务数据对比。点击上方公司名可切换其他公司
Oncology Institute, Inc.的季度营收约是弗雷斯特研究公司的1.4倍（$142.0M vs $101.1M），Oncology Institute, Inc.净利率更高（-5.3% vs -33.5%，领先28.2%），Oncology Institute, Inc.同比增速更快（41.6% vs -6.5%），Oncology Institute, Inc.自由现金流更多（$2.2M vs $-4.3M），过去两年Oncology Institute, Inc.的营收复合增速更高（22.5% vs 0.5%）
福雷斯特研究公司是一家全球领先的研究咨询机构，主营业务涵盖行业研究、管理咨询与行业峰会举办，客户群体包括全球大型企业、科技公司与消费领域领军企业，公司总部位于美国马萨诸塞州剑桥市。
肿瘤研究所股份有限公司是一家专注于肿瘤诊疗领域的专业医疗企业，提供循证抗癌治疗方案、临床试验参与通道及配套支持护理服务，主要面向美国境内各类癌症患者，协同医疗从业者优化诊疗效果。
FORR vs TOI — 直观对比
营收规模更大
TOI
是对方的1.4倍
$101.1M
营收增速更快
TOI
高出48.0%
-6.5%
净利率更高
TOI
高出28.2%
-33.5%
自由现金流更多
TOI
多$6.4M
$-4.3M
两年增速更快
TOI
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $101.1M | $142.0M |
| 净利润 | $-33.9M | $-7.5M |
| 毛利率 | 56.7% | — |
| 营业利润率 | -36.6% | -4.9% |
| 净利率 | -33.5% | -5.3% |
| 营收同比 | -6.5% | 41.6% |
| 净利润同比 | -7941.4% | 43.0% |
| 每股收益（稀释后） | $-1.75 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORRTOI
| Q4 25 | $101.1M | $142.0M | ||
| Q3 25 | $94.3M | $136.6M | ||
| Q2 25 | $111.7M | $119.8M | ||
| Q1 25 | $89.9M | $104.4M | ||
| Q4 24 | $108.0M | $100.3M | ||
| Q3 24 | $102.5M | $99.9M | ||
| Q2 24 | $121.8M | $98.6M | ||
| Q1 24 | $100.1M | $94.7M |
净利润FORRTOI
| Q4 25 | $-33.9M | $-7.5M | ||
| Q3 25 | $-2.1M | $-16.5M | ||
| Q2 25 | $3.9M | $-17.0M | ||
| Q1 25 | $-87.3M | $-19.6M | ||
| Q4 24 | $432.0K | $-13.2M | ||
| Q3 24 | $-5.8M | $-16.1M | ||
| Q2 24 | $6.3M | $-15.5M | ||
| Q1 24 | $-6.7M | $-19.9M |
毛利率FORRTOI
| Q4 25 | 56.7% | — | ||
| Q3 25 | 60.0% | — | ||
| Q2 25 | 55.5% | — | ||
| Q1 25 | 55.9% | — | ||
| Q4 24 | 58.8% | — | ||
| Q3 24 | 60.5% | — | ||
| Q2 24 | 57.3% | — | ||
| Q1 24 | 54.9% | — |
营业利润率FORRTOI
| Q4 25 | -36.6% | -4.9% | ||
| Q3 25 | 4.7% | -5.9% | ||
| Q2 25 | 6.2% | -9.4% | ||
| Q1 25 | -97.5% | -9.5% | ||
| Q4 24 | -0.5% | -11.9% | ||
| Q3 24 | -0.7% | -13.9% | ||
| Q2 24 | 9.3% | -16.6% | ||
| Q1 24 | -9.3% | -19.0% |
净利率FORRTOI
| Q4 25 | -33.5% | -5.3% | ||
| Q3 25 | -2.3% | -12.1% | ||
| Q2 25 | 3.5% | -14.2% | ||
| Q1 25 | -97.1% | -18.8% | ||
| Q4 24 | 0.4% | -13.1% | ||
| Q3 24 | -5.7% | -16.1% | ||
| Q2 24 | 5.2% | -15.7% | ||
| Q1 24 | -6.7% | -21.0% |
每股收益（稀释后）FORRTOI
| Q4 25 | $-1.75 | $-0.04 | ||
| Q3 25 | $-0.11 | $-0.14 | ||
| Q2 25 | $0.20 | $-0.15 | ||
| Q1 25 | $-4.62 | $-0.21 | ||
| Q4 24 | $0.02 | $-0.14 | ||
| Q3 24 | $-0.30 | $-0.18 | ||
| Q2 24 | $0.33 | $-0.17 | ||
| Q1 24 | $-0.35 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.3M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $126.5M | $-15.7M |
| 总资产 | $404.0M | $164.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FORRTOI
| Q4 25 | $63.3M | — | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $67.8M | — | ||
| Q1 25 | $75.6M | — | ||
| Q4 24 | $56.1M | — | ||
| Q3 24 | $62.8M | — | ||
| Q2 24 | $58.9M | $9.9M | ||
| Q1 24 | $61.4M | $29.8M |
股东权益FORRTOI
| Q4 25 | $126.5M | $-15.7M | ||
| Q3 25 | $157.7M | $-12.3M | ||
| Q2 25 | $159.5M | $-9.0M | ||
| Q1 25 | $147.4M | $5.1M | ||
| Q4 24 | $229.5M | $3.6M | ||
| Q3 24 | $234.3M | $15.5M | ||
| Q2 24 | $237.1M | $29.2M | ||
| Q1 24 | $230.9M | $41.3M |
总资产FORRTOI
| Q4 25 | $404.0M | $164.7M | ||
| Q3 25 | $414.2M | $163.6M | ||
| Q2 25 | $436.0M | $159.8M | ||
| Q1 25 | $439.8M | $164.0M | ||
| Q4 24 | $503.9M | $172.7M | ||
| Q3 24 | $505.3M | $179.2M | ||
| Q2 24 | $524.2M | $179.6M | ||
| Q1 24 | $555.7M | $204.5M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.2M | $3.2M |
| 自由现金流经营现金流 - 资本支出 | $-4.3M | $2.2M |
| 自由现金流率自由现金流/营收 | -4.2% | 1.5% |
| 资本支出强度资本支出/营收 | 1.1% | 0.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $18.1M | $-27.8M |
8季度趋势，按日历期对齐
经营现金流FORRTOI
| Q4 25 | $-3.2M | $3.2M | ||
| Q3 25 | $1.2M | $-12.6M | ||
| Q2 25 | $-3.6M | $-10.2M | ||
| Q1 25 | $26.7M | $-5.0M | ||
| Q4 24 | $-1.8M | $4.2M | ||
| Q3 24 | $264.0K | $819.0K | ||
| Q2 24 | $-2.9M | $-15.7M | ||
| Q1 24 | $611.0K | $-15.9M |
自由现金流FORRTOI
| Q4 25 | $-4.3M | $2.2M | ||
| Q3 25 | $524.0K | $-13.2M | ||
| Q2 25 | $-4.2M | $-11.4M | ||
| Q1 25 | $26.1M | $-5.3M | ||
| Q4 24 | $-2.5M | $2.4M | ||
| Q3 24 | $-223.0K | $417.0K | ||
| Q2 24 | $-3.7M | $-17.5M | ||
| Q1 24 | $-815.0K | $-16.5M |
自由现金流率FORRTOI
| Q4 25 | -4.2% | 1.5% | ||
| Q3 25 | 0.6% | -9.7% | ||
| Q2 25 | -3.8% | -9.5% | ||
| Q1 25 | 29.0% | -5.1% | ||
| Q4 24 | -2.3% | 2.4% | ||
| Q3 24 | -0.2% | 0.4% | ||
| Q2 24 | -3.1% | -17.7% | ||
| Q1 24 | -0.8% | -17.4% |
资本支出强度FORRTOI
| Q4 25 | 1.1% | 0.7% | ||
| Q3 25 | 0.7% | 0.4% | ||
| Q2 25 | 0.5% | 1.0% | ||
| Q1 25 | 0.7% | 0.3% | ||
| Q4 24 | 0.6% | 1.8% | ||
| Q3 24 | 0.5% | 0.4% | ||
| Q2 24 | 0.7% | 1.9% | ||
| Q1 24 | 1.4% | 0.6% |
现金转化率FORRTOI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.93× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -4.24× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.46× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORR
| Research Segment | $82.2M | 81% |
| Consulting Segment | $16.2M | 16% |
| Billable Expenses | $1.5M | 2% |
| Professional Services | $1.4M | 1% |
TOI
| Other | $82.1M | 58% |
| Fee For Service | $36.3M | 26% |
| Capitated Revenue | $23.6M | 17% |
